Renaissance Technologies
ETTX

Renaissance Technologies’s Entasis Therapeutics Holdings Inc. ETTX Stock Holding History

Renaissance Technologies’s Portfolio ETTX Stock Details ETTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-350,345
Closed -$771K – 4602
2022
Q2 		$771K Buy
350,345
+26,500
+8% +$52.9K ﹤0.01% 2878
2022
Q1 		$606K Buy
323,845
+500
+0.2% +$910 ﹤0.01% 3059
2021
Q4 		$708K Buy
323,345
+10,800
+3% +$29.2K ﹤0.01% 2901
2021
Q3 		$1.04M Sell
312,545
-79,084
-20% -$214K ﹤0.01% 2523
2021
Q2 		$1.05M Sell
391,629
-394,977
-50% -$892K ﹤0.01% 2642
2021
Q1 		$1.68M Buy
786,606
+280,217
+55% +$796K ﹤0.01% 2325
2020
Q4 		$1.25M Buy
506,389
+265,548
+110% +$522K ﹤0.01% 2390
2020
Q3 		$491K Buy
240,841
+143,395
+147% +$409K ﹤0.01% 2816
2020
Q2 		$288K Buy
97,446
+62,343
+178% +$170K ﹤0.01% 3057
2020
Q1 		$93K Buy
35,103
+9,803
+39% +$44.2K ﹤0.01% 3243
2019
Q4 		$126K Buy
25,300
+7,600
+43% +$41.1K ﹤0.01% 3275
2019
Q3 		$105K Buy
+17,700
New +$119K ﹤0.01% 3258

Renaissance Technologies's ETTX Position: Q3 2022 in Review

Renaissance Technologies sold out of Entasis Therapeutics Holdings Inc. (ETTX) in Q3 2022, closing a stake of 350,345 shares — an estimated $771K sold.

Renaissance Technologies first reported a position in ETTX in Q3 2019 and held it in 12 quarters. The position peaked at $1.68M in Q1 2021. 0 funds tracked by Wall St. Rank hold ETTX as of Q3 2022.

  • Renaissance Technologies reported no remaining Entasis Therapeutics Holdings Inc. position as of Q3 2022 after selling out during the quarter.
  • Renaissance Technologies sold 350,345 Entasis Therapeutics Holdings Inc. shares in Q3 2022, an estimated $771K.
  • Renaissance Technologies first reported a position in Entasis Therapeutics Holdings Inc. in Q3 2019 and held it in 12 quarters.
  • Renaissance Technologies's Entasis Therapeutics Holdings Inc. position peaked at $1.68M in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Entasis Therapeutics Holdings Inc. as of Q3 2022.

Based on Renaissance Technologies's 13F filing for Q3 2022, filed 14 Nov 2022.